Precision BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	44.87	85.9	116.68	189.58	143.66	89.8
Short-Term Investments	-	0.41	-	-	-	-
Cash & Short-Term Investments	44.87	86.31	116.68	189.58	143.66	89.8
Cash Growth	-55.66%	-26.02%	-38.45%	31.96%	59.98%	-50.36%
Accounts Receivable	0	1.7	0.9	0.72	0.49	10
Receivables	0	1.7	12.8	0.72	0.49	10
Prepaid Expenses	5.86	6.44	5.98	6.03	17.43	5.76
Other Current Assets	0.97	0.54	0.91	2.78	0.17	0
Total Current Assets	51.71	94.99	136.36	199.11	161.75	105.56
Property, Plant & Equipment	8.16	10.18	14.6	13.78	29.33	41.5
Long-Term Investments	0.74	3.21	3.21	4.75	6.84	-
Other Intangible Assets	0.99	0.62	0.4	0.73	2.05	1.37
Other Long-Term Assets	26.54	22.79	0.23	12.57	4.64	1.72
Total Assets	93.51	136.39	159.78	238.17	211.5	150.16
Accounts Payable	1.34	1.31	2.97	0.65	1.14	0.79
Accrued Expenses	4.45	7.2	6.54	6.93	10.79	9.01
Short-Term Debt	-	-	22.41	-	-	-
Current Portion of Leases	1.46	1.32	1.13	1.68	1.82	1.93
Current Unearned Revenue	6.25	2.96	12.04	46.19	21.24	30.24
Other Current Liabilities	1.5	2.19	4.9	4.21	0.98	0.85
Total Current Liabilities	15	14.98	49.99	59.66	35.98	42.83
Long-Term Debt	22.37	22.32	-	22.22	2.48	-
Long-Term Leases	5.3	6.4	7.72	1.06	4.81	8.59
Long-Term Unearned Revenue	29.96	33.3	83.08	92.87	77.02	53.93
Other Long-Term Liabilities	4.25	2.99	0.13	1.92	0.04	0.39
Total Liabilities	76.88	80	140.92	177.74	120.33	105.73
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	565.91	539.81	509.44	489.7	408.8	331.45
Retained Earnings	-548.32	-482.46	-489.63	-428.31	-316.68	-286.07
Treasury Stock	-0.95	-0.95	-0.95	-0.95	-0.95	-0.95
Total Common Equity	16.63	56.39	18.86	60.43	91.17	44.43
Shareholders' Equity	16.63	56.39	18.86	60.43	91.17	44.43
Total Liabilities & Equity	93.51	136.39	159.78	238.17	211.5	150.16
Total Debt	29.13	30.05	31.27	24.96	9.11	10.52
Net Cash (Debt)	15.74	56.27	85.41	164.62	134.55	79.28
Net Cash Growth	-77.80%	-34.12%	-48.12%	22.35%	69.72%	-56.17%
Net Cash Per Share	1.57	8.17	22.23	56.19	68.78	45.71
Filing Date Shares Outstanding	13.26	10.48	6.92	3.71	2.03	1.9
Total Common Shares Outstanding	12.08	8.2	4.16	3.7	2.03	1.76
Working Capital	36.71	80.01	86.37	139.44	125.77	62.74
Book Value Per Share	1.38	6.87	4.53	16.34	44.91	25.29
Tangible Book Value	15.65	55.77	18.46	59.7	89.12	43.05
Tangible Book Value Per Share	1.30	6.80	4.43	16.14	43.90	24.51
Machinery	-	18.7	19.38	20.78	22.93	25.3
Construction In Progress	-	0.01	0.07	0.52	3.04	1.89
Leasehold Improvements	-	12.03	11.95	11.95	22.78	26.58

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q